Clinical trials
Hypertension trials in Germany with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Unknown status | 13 |
| Active, not recruiting | 7 |
| Recruiting | 6 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medtronic Vascular | 9 |
| University of Erlangen-Nürnberg Medical School | 5 |
| CVRx, Inc. | 4 |
| Charite University, Berlin, Germany | 4 |
| German Institute of Human Nutrition | 3 |
| ReCor Medical, Inc. | 3 |
| Universität Duisburg-Essen | 2 |
| Vascular Dynamics, Inc. | 2 |
| Abbott Medical Devices | 1 |
| Ablative Solutions, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 62 |
| Cardiovascular Diseases | 11 |
| Vascular Diseases | 9 |
| Renal Insufficiency, Chronic | 7 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Metabolic Syndrome | 5 |
| Essential Hypertension | 4 |
| Obesity | 4 |
| Atrial Fibrillation | 3 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.